Investor Alley Inc.

Gainers in Today's Trading Session: (NASDAQ: KERX), (NASDAQ: AEZS)


New York, NY -- (ReleaseWire) -- 01/29/2013 --Keryx Biopharmaceuticals Inc. (NASDAQ: KERX) stock is at $8.09, up 33.60 percent from its previous close of $6.06. The stock shows bullish trend as it made the up move with trading volume of 34.459 million shares, in contrast to the average daily trading volume of 2.546 million shares. Its bullish trend is further confirmed by its MACD chart and the stock is also trading higher than its 13 days EMA of $4.27. The stock may go as high as $8.35 in its coming trading sessions.

Keryx Biopharmaceuticals stock has received price target upgrade from StifelNicolaus. Its new price target is $13, up from previous target of $4.

Find out more on KERX here:

AeternaZentaris (NASDAQ: AEZS) opened at $2.76 and oscillated in the range of $2.74 and $3.45 in the latest trading session. It is currently at $3.25, up 18.18 percent from its previous close of $2.75. AeternaZentaris shows bullish trend and the stock’s first resistance level is at $4.04. Upon breaching this level, the stock may touch $5.34. On the downside, it may slip to $2.40. The stock has traded 3.306 million shares so far.

AeternaZentaris is a late stage biopharmaceutical company. It develops and markets therapies for cancer and endocrine ailments.

Find out where AEZS could be headed by getting the free full report here:

About issues momentum alerts on stocks that can provide gains to day traders and short-term investors. provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains. monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:

Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

Contact Info:
Thomas Greene
Wall Street Scoop